[基于多重数据挖掘的国家专利数据库中治疗心痛的中国草药化合物处方的药物规则]
Cheng-Sheng Chen1, Kang Jing1, Yan-Meng Guo1
1Hubei University of Chinese Medicine Wuhan 430000, China.
概括
这项研究分析了中国的草药专利,以揭示心痛的药物规则,识别了像Salviae Miltiorrhizae Radix et Rhizoma这样的关键草药和常见的综合征,如血液静止. 这些发现为临床治疗和新药开发提供了洞察力.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 数据挖掘 数据挖掘
背景情况:
- 胸痛治疗往往涉及中国草药化合物处方.
- 了解药物规则对于有效治疗和药物开发至关重要.
研究的目的:
- 通过使用专利数据,探索中国草药化合物处方治疗心痛的药物规则.
- 确定用于心痛治疗的核心药物组合和关联规则.
主要方法:
- 来自中国国家知识产权管理局数据库的中国草药化合物专利对心痛的数据挖掘.
- 分析包括主要综合征,药物使用频率,集群分析和关联规则分析.
主要成果:
- 分析了涉及815种药物的636项专利.
- 阻碍心脏的血液静止和 Qi 缺乏和血液静止是主要的综合征.
- 萨尔维亚 (Salviae Miltiorrhizae Radix et Rhizoma) 草根,楚安雄草根和诺托金森草根是关键的草药,通常与调色剂结合.
结论:
- 胸痛的药物规则与临床实践保持一致,强调激活血液,缓解静止和 tonifying 草药.
- 确定了新的化合物处方和药物组合,为临床应用和新药开发提供了洞察力.
关键词:
中国的草药化合物.焦虑症 (angina) 是一种心痛.数据挖掘是数据挖掘的一个方法.药物规则 药物规则 药物规则patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
543
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
591
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
596
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
596
01:25Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
648
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
648
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
526
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
526
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436